Nicholas Alexander Livingston, PhD

Assistant Professor, Psychiatry

Nicholas Livingston
857.364.6612

Biography

Dr. Livingston received his Bachelors in Psychology and Drug and Alcohol Use Counseling from the University of Utah, then his Masters and Doctorate in Clinical Psychology from the University of Montana. Dr. Livingston completed his predoctoral internship at the VA Boston Healthcare System, including rotations in the outpatient Alcohol and Drug Treatment Program (ADTP), Substance Abuse Residential Rehabilitation Treatment Program (SARRTP), and Women’s Trauma Recovery Program (WTRP). Dr. Livingston subsequently completed the 2-year VA Interprofessional Advanced Fellowship in Addiction Treatment (postdoctoral research fellowship) at VA Boston Healthcare System, which included rotations in substance use and posttraumatic stress disorder (PTSD) treatment at VA Boston and VA Brockton Medical Centers. Dr. Livingston is currently a Research Psychologist in the National Center for PTSD, Behavioral Science Division, and an Assistant Professor in the Department of Psychiatry at Chobanian and Avedisian School of Medicine.

Dr. Livingston maintains several active lines of research. Primary foci of his current program include:
1) studies on the co-occurrence of trauma/PTSD and substance use disorder
2) development and evaluation of mobile and web-based interventions for substance use and PTSD (e.g., VetChange)
3) examinations of mental health disparities, healthcare needs, and the effects of minority stress on health among lesbian, gay, bisexual, and transgender (LGBT) individuals.

Dr. Livingston is also actively involved in research to examine the longitudinal course of trauma exposure, discrimination, and mental health using diverse data collection methods (e.g., ecological momentary assessment) and novel assessment strategies.

Education

  • University of Montana, PhD

Publications

  • Published on 6/24/2024

    Harper KL, Blosnich JR, Livingston N, Vogt D, Bernhard PA, Hoffmire CA, Maguen S, Schneiderman A. Trauma exposure, mental health, and mental health treatment among LGBTQ+ veterans and nonveterans. Psychol Trauma. 2024 Jun 24. PMID: 38913715.

    Read at: PubMed
  • Published on 6/5/2024

    LeBeau LS, White MC, Henke RM, Hyde J, Sarpong A, Weisberg RB, Livingston NA, Mulvaney-Day N. Considerations for Opioid Use Disorder Treatment From Policy Makers' Experiences With COVID-19 Policy Flexibilities. Psychiatr Serv. 2024 Jun 05; appips20230260. PMID: 38835255.

    Read at: PubMed
  • Published on 5/10/2024

    Jasuja GK, Wolfe HL, Reisman JI, Vimalananda VG, Rao SR, Blosnich JR, Livingston NA, Shipherd JC. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations. Front Endocrinol (Lausanne). 2024; 15:1086158. PMID: 38800485.

    Read at: PubMed
  • Published on 5/9/2024

    Chang CJ, Livingston NA, Rashkovsky KT, Harper KL, Kuehn KS, Khalifian C, Harned MS, Tucker RP, Depp CA. A Scoping Review of Suicide Prevention Interventions for Lesbian, Gay, Bisexual, Transgender, Queer, and Other Sexual and Gender Minority Individuals. LGBT Health. 2024 May 09. PMID: 38722250.

    Read at: PubMed
  • Published on 4/3/2024

    Wolfe HL, Vimalananda VG, Wong DH, Reisman JI, Rao SR, Shipherd JC, Blosnich JR, Livingston NA, Jasuja GK. Patient Characteristics Associated with Receiving Gender-Affirming Hormone Therapy in the Veterans Health Administration. Transgend Health. 2024 Apr; 9(2):151-161. PMID: 38694620.

    Read at: PubMed
  • Published on 3/4/2024

    Valentine SE, Gell-Levey IM, Godfrey LB, Livingston NA. The Associations Between Gender Minority Stressors and PTSD Symptom Severity Among Trauma-Exposed Transgender and Gender Diverse Adults. J Trauma Dissociation. 2024; 25(4):422-435. PMID: 38436077.

    Read at: PubMed
  • Published on 2/25/2024

    Mathes Winnicki BM, Lee DJ, Hawn SE, Livingston NA, Marx BP, Keane TM. Alcohol consumption and dependence risk among male and female Veterans: Trajectories and predictors. Drug Alcohol Depend. 2024 Apr 01; 257:111138. PMID: 38430789.

    Read at: PubMed
  • Published on 1/1/2024

    Salomaa AC, Berke D, Harper K, Valentine SE, Sloan CA, Hinds Z, Gyuro L, Herbitter C, Bryant WT, Shipherd JC, Livingston NA. A patient-centered model of mental health care for trauma and minority stress in transgender and gender diverse people: A bottom-up network analysis. Psychol Sex Orientat Gend Divers. 2024; 2024. PMID: 38765785.

    Read at: PubMed
  • Published on 11/2/2023

    Bryant WT, Livingston NA, McNulty JL, Choate KT, Santa Ana EJ, Ben-Porath YS. Exploring the Minnesota Multiphasic Personality Inventory (MMPI)-3 in a transgender and gender diverse sample. Psychol Assess. 2024 Jan; 36(1):1-13. PMID: 37917494.

    Read at: PubMed
  • Published on 10/20/2023

    Livingston NA, Sarpong A, Sistad R, Roth C, Banducci AN, Simpson T, Hyde J, Davenport M, Weisberg R. Gender differences in receipt of telehealth versus in person behavioral therapy, medication for opioid use disorder (MOUD), and 90-day MOUD retention during the pandemic: A retrospective veteran cohort study. J Subst Use Addict Treat. 2024 Jan; 156:209188. PMID: 37866437.

    Read at: PubMed

View 45 more publications: View full profile at BUMC

View all profiles